WuXi Biologics Recognized by CDP for Climate Change Leadership for Second Consecutive Year
WuXi Biologics (2269.HK) has received recognition from CDP for its climate change leadership for the second consecutive year, achieving an 'A-' score among 25,000 reporting companies. The global CRDMO announced this achievement on Earth Day 2025.
The company has committed to achieving net-zero emissions by 2050 and has already achieved a 30% reduction in GHG emission intensity from 2020 levels in 2024. Notable sustainability initiatives include implementing rooftop photovoltaic power projects and achieving 100% renewable electricity at its Ireland facility.
WuXi Biologics has garnered multiple sustainability accolades, including an MSCI AAA Rating, EcoVadis Platinum Medal, and inclusion in the Dow Jones Sustainability Indices. The company participates in the United Nations Global Compact and Pharmaceutical Supply Chain Initiative, demonstrating its commitment to environmental stewardship and sustainable practices throughout its value chain.
WuXi Biologics (2269.HK) ha ricevuto per il secondo anno consecutivo il riconoscimento da CDP per la sua leadership nel cambiamento climatico, ottenendo un punteggio di 'A-' tra 25.000 aziende partecipanti. Il CRDMO globale ha annunciato questo risultato in occasione della Giornata della Terra 2025.
L'azienda si è impegnata a raggiungere emissioni nette zero entro il 2050 e ha già ridotto del 30% l'intensità delle emissioni di gas serra rispetto ai livelli del 2020, raggiungendo questo traguardo nel 2024. Tra le iniziative di sostenibilità più rilevanti vi sono l'installazione di impianti fotovoltaici sui tetti e l'adozione di energia elettrica al 100% da fonti rinnovabili presso la struttura in Irlanda.
WuXi Biologics ha ottenuto numerosi riconoscimenti per la sostenibilità, tra cui il rating MSCI AAA, la medaglia Platinum di EcoVadis e l'inclusione negli Indici di Sostenibilità Dow Jones. L'azienda partecipa al Patto Globale delle Nazioni Unite e all'Iniziativa per la Catena di Fornitura Farmaceutica, dimostrando il suo impegno nella tutela ambientale e nelle pratiche sostenibili lungo tutta la sua filiera.
WuXi Biologics (2269.HK) ha recibido reconocimiento de CDP por su liderazgo en cambio climático por segundo año consecutivo, logrando una puntuación de 'A-' entre 25,000 empresas reportantes. El CRDMO global anunció este logro en el Día de la Tierra 2025.
La compañía se ha comprometido a alcanzar emisiones netas cero para 2050 y ya ha logrado una reducción del 30% en la intensidad de emisiones de gases de efecto invernadero respecto a los niveles de 2020 en 2024. Entre las iniciativas destacadas de sostenibilidad se incluyen la implementación de proyectos fotovoltaicos en los techos y el uso de electricidad 100% renovable en su planta en Irlanda.
WuXi Biologics ha recibido múltiples reconocimientos en sostenibilidad, incluyendo una calificación MSCI AAA, la Medalla Platino de EcoVadis y la inclusión en los Índices de Sostenibilidad Dow Jones. La empresa participa en el Pacto Global de las Naciones Unidas y en la Iniciativa de la Cadena de Suministro Farmacéutica, demostrando su compromiso con la protección ambiental y prácticas sostenibles a lo largo de toda su cadena de valor.
WuXi Biologics (2269.HK)는 2년 연속 CDP로부터 기후 변화 리더십을 인정받아 25,000개 보고 기업 중 'A-' 등급을 획득했습니다. 이 글로벌 CRDMO는 2025년 지구의 날에 이 성과를 발표했습니다.
회사는 2050년까지 탄소 순배출 제로를 달성하겠다는 목표를 세웠으며, 2024년에는 2020년 대비 온실가스 배출 강도를 30% 감축했습니다. 주목할 만한 지속가능성 이니셔티브로는 옥상 태양광 발전 프로젝트 시행과 아일랜드 시설에서 100% 재생에너지 전력 사용이 포함됩니다.
WuXi Biologics는 MSCI AAA 등급, EcoVadis 플래티넘 메달, 다우존스 지속가능성 지수 포함 등 다수의 지속가능성 상을 받았습니다. 또한 유엔 글로벌 콤팩트와 제약 공급망 이니셔티브에 참여하며, 가치 사슬 전반에 걸쳐 환경 보호와 지속 가능한 실천에 대한 의지를 보여주고 있습니다.
WuXi Biologics (2269.HK) a été reconnu par le CDP pour sa leadership en matière de changement climatique pour la deuxième année consécutive, obtenant une note de « A- » parmi 25 000 entreprises déclarantes. Ce CRDMO mondial a annoncé cette réussite lors de la Journée de la Terre 2025.
L’entreprise s’est engagée à atteindre la neutralité carbone d’ici 2050 et a déjà réduit de 30 % l’intensité des émissions de gaz à effet de serre par rapport aux niveaux de 2020, en 2024. Parmi les initiatives durables notables figurent la mise en place de projets photovoltaïques sur les toits et l’utilisation à 100 % d’électricité renouvelable dans son site en Irlande.
WuXi Biologics a reçu plusieurs distinctions en matière de durabilité, notamment la notation MSCI AAA, la médaille Platine EcoVadis et l’inclusion dans les indices de durabilité Dow Jones. L’entreprise participe au Pacte mondial des Nations Unies et à l’Initiative pour la chaîne d’approvisionnement pharmaceutique, démontrant son engagement envers la protection de l’environnement et les pratiques durables tout au long de sa chaîne de valeur.
WuXi Biologics (2269.HK) wurde zum zweiten Mal in Folge von CDP für seine Führungsrolle im Klimaschutz anerkannt und erzielte unter 25.000 berichtenden Unternehmen eine Bewertung von 'A-'. Das globale CRDMO gab diese Auszeichnung am Earth Day 2025 bekannt.
Das Unternehmen hat sich verpflichtet, bis 2050 Netto-Null-Emissionen zu erreichen, und hat bereits 2024 eine Reduktion der Treibhausgasintensität um 30 % gegenüber dem Niveau von 2020 erreicht. Zu den bemerkenswerten Nachhaltigkeitsinitiativen zählen die Installation von Photovoltaikanlagen auf Dächern und der Einsatz von 100 % erneuerbarem Strom an seinem Standort in Irland.
WuXi Biologics erhielt mehrere Nachhaltigkeitsauszeichnungen, darunter das MSCI AAA Rating, die EcoVadis-Platinmedaille und die Aufnahme in die Dow Jones Nachhaltigkeitsindizes. Das Unternehmen ist Teilnehmer des UN Global Compact und der Pharmaceutical Supply Chain Initiative, was sein Engagement für Umweltschutz und nachhaltige Praktiken entlang der gesamten Wertschöpfungskette unterstreicht.
- None.
- None.
- Firm commitment to tackling climate change in support of United Nations Sustainable Development Goals
- Earth Day 2025 - Our Power, Our Planet, Contribute to a sustainable future
CDP is recognized as the global standard for corporate environmental reporting, and its annually published ratings are widely used to drive investment and procurement decisions toward a net-zero, sustainable and resilient economy. Companies are evaluated on their awareness of environmental issues, management methods and advancements in environmental stewardship. In 2024, nearly 25,000 companies — representing two-thirds of the global market value — reported their environmental data through CDP. WuXi Biologics stood out among these companies with an "A-" score for leadership on climate change.
Committed to the Science Based Target initiative (SBTi), WuXi Biologics has adopted an integrated strategy to tackle climate change issues, with measurable targets and a refined roadmap. The Company aims to achieve net-zero emissions from overall operations by 2050, and in 2024, it realized a
Dr. Chris Chen, CEO of WuXi Biologics and Chairman of its ESG Committee, commented, "We are very pleased to be recognized once again by CDP for climate change leadership, an acknowledgement that further inspires our steadfast dedication to enhancing our sustainability performance. It is fitting that we are making this announcement on Earth Day as we, along with organizations and communities around the world, put special focus on the importance of long-term ecological sustainability. As a global leader in Green CRDMO, we consistently deliver ESG excellence, enable partners worldwide with end-to-end solutions to fulfil their ESG commitments, and work together with all of our stakeholders to promote responsible practices throughout the entire value chain."
As a participant of the United Nations Global Compact (UNGC) and the Pharmaceutical Supply Chain Initiative (PSCI), WuXi Biologics proactively advocates sustainability, and has earned widespread recognition for its efforts. It was granted an MSCI AAA Rating; awarded an EcoVadis Platinum Medal; listed in the Dow Jones Sustainability Indices (DJSI) for two consecutive years; included in the UNGC 20 Case Examples of Sustainable Development for 20 Years Collection for its world-leading green biologics solutions; recognized as a Sustainalytics industry and regional ESG top-rated company for five consecutive years; merited an "A" CDP Water Security score; selected as a Constituent of the FTSE4Good Index Series; listed in the Hang Seng ESG 50 Index; and rated as Prime by ISS ESG Corporate Rating.
About CDP
CDP is a global non-profit that runs the world's only independent environmental disclosure system. As the founder of environmental reporting, the organization believes in transparency and the power of data to drive change. Partnering with leaders in enterprise, capital, policy and science, CDP surfaces the information needed to enable Earth-positive decisions. It helped more than 24,800 companies and 1,100 cities, states and regions disclose their environmental impacts in 2024. Financial institutions with more than a quarter of the world's institutional assets use CDP data to help inform investment and lending decisions. Aligned with the ISSB's climate standard, IFRS S2, as its foundational baseline, CDP integrates best-practice reporting standards and frameworks in one place. The team is truly global, united by a shared desire to build a world where people, planet and profit are truly balanced.
About WuXi Biologics
WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.
With over 12,000 skilled employees in
WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously drives green technology innovations to offer advanced end-to-end Green CRDMO solutions for its global partners while consistently achieving excellence in Environment, Social and Governance (ESG). Committed to creating shared value, it collaborates with all stakeholders to foster positive social and environmental impacts and promote responsible practices that empower the entire value chain.
For more information about WuXi Biologics, please visit: www.wuxibiologics.com.
View original content:https://www.prnewswire.com/news-releases/wuxi-biologics-recognized-by-cdp-for-climate-change-leadership-for-second-consecutive-year-302434077.html
SOURCE WuXi Biologics
FAQ
What environmental targets has WuXi Biologics achieved in 2024?
What is WuXi Biologics' net-zero emission target date?
How did WuXi Biologics perform in the 2025 CDP environmental assessment?
What sustainability certifications and ratings does WuXi Biologics currently hold?
What renewable energy initiatives has WuXi Biologics implemented?
